Brett L. Carlson

Induction of MGMT expression is associated with temozolomide resistance in glioblastoma xenografts

Gaspar J. Kitange, Brett L. Carlson, Mark A. Schroeder et al. · Neuro-Oncology · 2008 · 382 citations · Full text

Mgmt Promoter Methylation, Pathology, High-grade Gliomas +18

Patient tumor EGFR and PDGFRA gene amplificationsretained in an invasive intracranial xenograft model of glioblastomamultiforme

Caterina Giannini, Jann N. Sarkaria, Atsushi Saito et al. · Neuro-Oncology · 2005 · 323 citations · Full text

Flavopiridol (L86 8275; NSC 649890), a new kinase inhibitor for tumor therapy

H.H. Sedlacek, Jörg Czech, Ramachandra Naik et al. · International Journal of Oncology · 1996 · 277 citations

Chemoprevention Strategy, Pharmacotherapy, New Synthetic Flavone +18

Use of an Orthotopic Xenograft Model for Assessing the Effect of Epidermal Growth Factor Receptor Amplification on Glioblastoma Radiation Response

Jann N. Sarkaria, Brett L. Carlson, Mark A. Schroeder et al. · Clinical Cancer Research · 2006 · 276 citations

Down-regulation of cyclin D1 by transcriptional repression in MCF-7 human breast carcinoma cells induced by flavopiridol.

Brett L. Carlson, Tyler Lahusen, Shradha Singh et al. · PubMed · 1999 · 254 citations

Breast Oncology, Chemoprevention Strategy, Cyclin D1 +19